These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 23754751)
1. Dual phosphorylation of Btk by Akt/protein kinase b provides docking for 14-3-3ζ, regulates shuttling, and attenuates both tonic and induced signaling in B cells. Mohammad DK; Nore BF; Hussain A; Gustafsson MO; Mohamed AJ; Smith CI Mol Cell Biol; 2013 Aug; 33(16):3214-26. PubMed ID: 23754751 [TBL] [Abstract][Full Text] [Related]
2. Bruton's tyrosine kinase is required for activation of IkappaB kinase and nuclear factor kappaB in response to B cell receptor engagement. Petro JB; Rahman SM; Ballard DW; Khan WN J Exp Med; 2000 May; 191(10):1745-54. PubMed ID: 10811867 [TBL] [Abstract][Full Text] [Related]
3. Regulation of nucleocytoplasmic shuttling of Bruton's tyrosine kinase (Btk) through a novel SH3-dependent interaction with ankyrin repeat domain 54 (ANKRD54). Gustafsson MO; Hussain A; Mohammad DK; Mohamed AJ; Nguyen V; Metalnikov P; Colwill K; Pawson T; Smith CI; Nore BF Mol Cell Biol; 2012 Jul; 32(13):2440-53. PubMed ID: 22527282 [TBL] [Abstract][Full Text] [Related]
4. Bruton's tyrosine kinase inhibition induces rewiring of proximal and distal B-cell receptor signaling in mice. Rip J; de Bruijn MJW; Neys SFH; Singh SP; Willar J; van Hulst JAC; Hendriks RW; Corneth OBJ Eur J Immunol; 2021 Sep; 51(9):2251-2265. PubMed ID: 34323286 [TBL] [Abstract][Full Text] [Related]
5. A phosphorylation site in Bruton's tyrosine kinase selectively regulates B cell calcium signaling efficiency by altering phospholipase C-gamma activation. Guo S; Ferl GZ; Deora R; Riedinger M; Yin S; Kerwin JL; Loo JA; Witte ON Proc Natl Acad Sci U S A; 2004 Sep; 101(39):14180-5. PubMed ID: 15375214 [TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of CD19 Y484 and Y515, and linked activation of phosphatidylinositol 3-kinase, are required for B cell antigen receptor-mediated activation of Bruton's tyrosine kinase. Buhl AM; Cambier JC J Immunol; 1999 Apr; 162(8):4438-46. PubMed ID: 10201980 [TBL] [Abstract][Full Text] [Related]
7. Myc enhances B-cell receptor signaling in precancerous B cells and confers resistance to Btk inhibition. Moyo TK; Wilson CS; Moore DJ; Eischen CM Oncogene; 2017 Aug; 36(32):4653-4661. PubMed ID: 28368423 [TBL] [Abstract][Full Text] [Related]
8. Syk and Bruton's tyrosine kinase are required for B cell antigen receptor-mediated activation of the kinase Akt. Craxton A; Jiang A; Kurosaki T; Clark EA J Biol Chem; 1999 Oct; 274(43):30644-50. PubMed ID: 10521450 [TBL] [Abstract][Full Text] [Related]
9. Bruton's tyrosine kinase targets NF-kappaB to the bcl-x promoter via a mechanism involving phospholipase C-gamma2 following B cell antigen receptor engagement. Petro JB; Castro I; Lowe J; Khan WN FEBS Lett; 2002 Dec; 532(1-2):57-60. PubMed ID: 12459462 [TBL] [Abstract][Full Text] [Related]
10. Bruton's tyrosine kinase mediates NF-kappa B activation and B cell survival by B cell-activating factor receptor of the TNF-R family. Shinners NP; Carlesso G; Castro I; Hoek KL; Corn RA; Woodland RT; Scott ML; Wang D; Khan WN J Immunol; 2007 Sep; 179(6):3872-80. PubMed ID: 17785824 [TBL] [Abstract][Full Text] [Related]
11. Phospholipase C-gamma 2 couples Bruton's tyrosine kinase to the NF-kappaB signaling pathway in B lymphocytes. Petro JB; Khan WN J Biol Chem; 2001 Jan; 276(3):1715-9. PubMed ID: 11042193 [TBL] [Abstract][Full Text] [Related]
12. Resistance Mutations to BTK Inhibitors Originate From the NF-κB but Not From the PI3K-RAS-MAPK Arm of the B Cell Receptor Signaling Pathway. Smith CIE; Burger JA Front Immunol; 2021; 12():689472. PubMed ID: 34177947 [TBL] [Abstract][Full Text] [Related]
13. Regulation of nuclear localization and transcriptional activity of TFII-I by Bruton's tyrosine kinase. Novina CD; Kumar S; Bajpai U; Cheriyath V; Zhang K; Pillai S; Wortis HH; Roy AL Mol Cell Biol; 1999 Jul; 19(7):5014-24. PubMed ID: 10373551 [TBL] [Abstract][Full Text] [Related]
14. Identification of Bruton's tyrosine kinase as a therapeutic target in acute myeloid leukemia. Rushworth SA; Murray MY; Zaitseva L; Bowles KM; MacEwan DJ Blood; 2014 Feb; 123(8):1229-38. PubMed ID: 24307721 [TBL] [Abstract][Full Text] [Related]
15. Transcription factor STAT5A is a substrate of Bruton's tyrosine kinase in B cells. Mahajan S; Vassilev A; Sun N; Ozer Z; Mao C; Uckun FM J Biol Chem; 2001 Aug; 276(33):31216-28. PubMed ID: 11413148 [TBL] [Abstract][Full Text] [Related]
17. Complementary roles for CD19 and Bruton's tyrosine kinase in B lymphocyte signal transduction. Fujimoto M; Poe JC; Satterthwaite AB; Wahl MI; Witte ON; Tedder TF J Immunol; 2002 Jun; 168(11):5465-76. PubMed ID: 12023340 [TBL] [Abstract][Full Text] [Related]
18. A conditional form of Bruton's tyrosine kinase is sufficient to activate multiple downstream signaling pathways via PLC Gamma 2 in B cells. Tomlinson MG; Woods DB; McMahon M; Wahl MI; Witte ON; Kurosaki T; Bolen JB; Johnston JA BMC Immunol; 2001; 2():4. PubMed ID: 11410123 [TBL] [Abstract][Full Text] [Related]
19. Activation of Bruton's tyrosine kinase (BTK) by a point mutation in its pleckstrin homology (PH) domain. Li T; Tsukada S; Satterthwaite A; Havlik MH; Park H; Takatsu K; Witte ON Immunity; 1995 May; 2(5):451-60. PubMed ID: 7538439 [TBL] [Abstract][Full Text] [Related]
20. Regulation of B lymphocyte development and activation by Bruton's tyrosine kinase. Khan WN Immunol Res; 2001; 23(2-3):147-56. PubMed ID: 11444380 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]